Dr. Barber on Neoadjuvant Chemotherapy in Ovarian Cancer

Emma Barber, MD, UNC Department of Obstetrics and Gynecology, UNC School of Medicine, UNC Lineberger Comprehensive Cancer Center, discusses neoadjuvant chemotherapy lowering readmission rates for patients with ovarian cancer.

According to Barber, the use of neoadjuvant chemotherapy will reduce the readmission rate, even in populations that are at higher risks for readmission.

It is important to individualize treatments to decide what will be benefit the patient long-term, explains Barber.